Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System

3 years ago

Powered by novel technology that can map a million cells in 10 minutes, the system enables unbiased spatial discovery across…

 aTyr Pharma Advances Development of Lead Therapeutic Candidate ATYR1923 with Announcement of “efzofitimod” as Nonproprietary Name

3 years ago

Efzofitimod expected to enter into a registrational trial for pulmonary sarcoidosis in 2022SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) --…

Piezo Motion, STXi Motion join forces to disrupt the precision motor market in Israel

3 years ago

Piezo Motion to deliver cost-effective industrial automation solutions to STXi’s customersNEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire…

An exciting joining of forces to support the Lachine Hospital!

3 years ago

Lachine Hospital Foundation is integrating with the McGill University Health Centre Foundation for a bigger impact Joining Forces to Support…

Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application

3 years ago

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a…

CinCor Pharma Appoints June Lee to Its Board of Directors

3 years ago

BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member…

BlueJay Therapeutics to Present at the 2nd Global IR@JPM Conference

3 years ago

SAN MATEO, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- BlueJay Therapeutics, a private biopharmaceutical company focused on cures for infectious…

Ascend Expands Testing Capacity with New Siemens Healthineers Strategic Relationship

3 years ago

The nation’s leading dialysis testing lab will become the biggest single-site user of Siemens Healthineers Atellica Solution analyzers in the…

Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-224, a Broad Immune Agonist, for the Treatment of Certain Solid Tumors

3 years ago

CAMBRIDGE, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically…

Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Growth Hormone Deficiency

3 years ago

TransCon hGH (approved by the European Commission as Lonapegsomatropin Ascendis Pharma) is a once-weekly prodrug of somatropin for pediatric patients…